Certara, Inc.

NasdaqGS:CERT

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

🌐 Software-as-a-Service (SaaS)

Location

United States

Market Cap

USD 1.77 B

Share Price

USD 11.02

Avg Daily Volume

1,674,485

Change (1 day)

0.46%

Change (1 year)

-9.38%

Change (YTD)

3.47%

Certara, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2025: 12.19%

Certara, Inc. EBITDA Margin is 12.19% for the Trailing 12 Months (TTM) ending June 30, 2025, a 2,661.72% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Certara, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was 0.44%, a -98.49% change year over year.
Certara, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was 29.19%, a 17.29% change year over year.
Certara, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was 24.89%, a 892.58% change year over year.
Certara, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was 2.51%, a -92.52% change year over year.